A drug from poison: How the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered

Science China Life Sciences

Volumn 56, Issue 6, 2013, Pages 495-502

  Rao, Yi ^a   Li, RunHong ^b   Zhang, DaQing ^b  

^a Tsinghua University   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

acute promyelocytic leukemia; arsenic trioxide; leukemia

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; ORGANOARSENIC DERIVATIVE; OXIDE;

ASIAN; CHINA; CHINESE MEDICINE; DRUG DEVELOPMENT; ETHNOLOGY; HUMAN; METHODOLOGY; PROMYELOCYTIC LEUKEMIA; REMISSION; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; ARSENICALS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DRUG DISCOVERY; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MEDICINE, CHINESE TRADITIONAL; OXIDES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84878785804     PISSN: 16747305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11427-013-4487-z     Document Type: Review

References (66)

1. Ellison R R, Holland J F, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood, 1968, 32: 507-523.
2. Boiron M, Weil M, Jacquillat C, et al. Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet, 1969, 293: 330-333.
3. Bernard J, Weil M, Boiron M, et al. Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood, 1973, 41: 489-496.
4. Bernard J, Weil M, Jacquillat C I. Treatment of acute granulocytic leukemias. Ann Rev Med, 1974, 25: 39-50.
5. Zhang T D, Zhang P F, Wang S R, et al. Preliminary clinical observations of six cases of leukemia treated by "Ailin solution" (in Chinese) 1). Med Pharm Heilongjiang, 1973, (3): 66-67.
6. Departments of Traditional Chinese Medicine and Laboratory Medicine of the First Affiliated Hospital of Harbin Medical University. Therapeutic observations of 17 cases leukemia treated with Ailin No. 1 and dialectic theory (in Chinese). J Harbin Med Univ, 1974, (2): 25-30.
7. Rong F X, Zhang T D. A report on long term survival of two cases of acute granulocytic leukemia (in Chinese). J New Med Pharm, 1979, (6): 31-34.
8. Zhang T D, Rong F X. Treatment of acute granulocytic leukemia by Ailin No. 1 and dialectic theory (in Chinese). Med Pharm Heilongjiang, 1979, (4): 7-11.
9. Huang M E, Ye Y C, Chen S R, et al. All-trans retinoic acid with or without low dose cytosine arabinoside in acute promyelocytic leukemia: report of six cases (in Chinese). Chin Med J, 1987, 100: 949-953.
10. Huang M E, Ye Y C, Chen S R, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 1988, 72: 567-572.
11. Sanz M A, Grimwade D, Tallman M S, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 2009, 113: 1875-1891.
12. Tallman M S, Altman J K. How I treat acute promyelocytic leukemia. Blood, 2009, 114: 51260-51235.
13. Sanz M A, Lo-Coco F. Modern approaches to treating acute promyelocytic leukemia. J Clin Oncol, 2011, 29: 495-503.
14. Powell B L, Moser B, Stock W, et al. Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710. Blood, 2010, 116: 3751-3757.
15. Estey E H. Newly diagnosed acute promyelocytic leukemia: arsenic moves front and center. J Clin Oncol, 2011, 29: 2743-2746.
16. Sears D A. History of the treatment of chronic myelocytic leukemia. Am J Med Sci, 1988, 296: 85-86.
17. Jolliffe D M. A history of the use of arsenicals in man. J Royal Soc Med, 1993, 86: 287-289.
18. Guan J R. Leukemia: clinical analysis of 49 cases (in Chinese). Heilongjiang Med, 1958, (2): 22-34.
19. Gu D X. Preliminary observations of the therapeutic effect of the traditional Chinese medicine "55" on leukemia (in Chinese). Harbin J Trad Chin Med, 1964, 5: 24.
20. Chaoyang People's Hospital Department of Pediatrics. Experience of using a combination of arsenic and chemotherapy to treat leukemia (in Chinese). Anti-Cancer Battle News of Liaoning (internally circulated materials, be careful in safekeeping, by the Office of Cancer Prevention and Treatment Research of Liaoning Province), 1972, (7): 23-24.
21. Hematology Group of the Department of Internal Medicine at Xiyuan Hospital of the Chinese Academy of Traditional Medicine. Treatment of leukemia by traditional Chinese medicine (in Chinese). Guangdong Med, 1974, (5): 31-37.
22. Zhou A X. Research on Qinghuang San treatment of leukemia (in Chinese). Chin J Integrat Trad West Med, 1998, 18: 582-583.
23. Department of Traditional Chinese Medicine of the First Affiliated Hospital of Harbin Medical University (Supervisor: Zhang T D. Writers: Li Y S, Hu X C. Participants: Li M X, Zhang P F, Rong F X, et al.). A clinical summary of 73 cases treated by Ailin No. 1 combined with the dialectic theory (in Chinese). Chin Med Pharm Heilongjiang, 1981, (4): 28-30.
24. Zhang T D. Comments on questions about designing clinical research with combined Chinese and Western medicine (in Chinese). J Integrat Trad Chin West Med, 1982, 2: 180-181.
25. Zhang T D. Understanding and treatment of leukemia by Chinese medicine (in Chinese). J Trad Chin Med, 1983, (3): 71-74.
26. Zhang T D, Li Y S. Clinical findings and experimental research of Ailin No. 1 in treating acute granuloleukemia (in Chinese). J Integrat Trad Chin West Med, 1984, 4: 19-20.
27. Zhang T D. Diagnosis and treatment of acute non-lymphatic leukemia (in Chinese). J Integrat Trad Chin West Med, 1985, 5: 713.
28. Sun H D, Ma L, Hu X C, et al. A report on 16 acute promyelocytic leukemia cases of long term survival treated by Ailin No. 1 in combination with traditional Chinese dialectic theories (in Chinese). Inf Trad Chin Med Pharm, 1991, (6): 39-41.
29. Sun H D, Ma L, Hu X C, et al. Ailin I treated 32 cases of acute promyelocytic leukemia (in Chinese). Chin J Integrat Chin West Med, 1992, 12: 170-172.
30. 3) treatment of 117 cases of acute promyelocytic leukemia: clinical observations and mechanistic investigations (in Chinese). J Harbin Med Univ, 1995, 29: 243.
31. Zhang P, Wang S Y, Hu L H, et al. Treatment of 72 cases of acute promyelocytic leukemia with intravenous arsenic trioxide (in Chinese). Chin J Hematol, 1996, 17: 58-62.
32. Collins S J, Gallo R C, Gallagher R E. Continuous growth and differentiation of human myeloid leukemic cells in suspension culture. Nature, 1977, 270: 347-349.
33. Breitman T R, Selonick S E, Collins S J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA, 1980, 70: 2936-2940.
34. Breitman T R, Collins S J, Keene B R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood, 1981, 57: 1000-1004.
35. Olsson I L, Breitman T R. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3′: 5′-monophosphate-inducing agents. C Cancer Res, 1982, 42: 3924-3927.
36. Honma Y, Fujita Y, Kasukabe T, et al. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60. Eur J Cancer Clin Oncol, 1983, 19: 251-261.
37. Koeffler H P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 1983, 62: 709-721.
38. Flynn P, Miller W, Weisdorf D, et al. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood, 1983, 62: 1211-1217.
39. Nilsson B. Probable in vivo induction of differentiation by retinoic acid acid of promyelocytes in acute promyelocytic leukemia. British J Haematol, 1984, 57: 365-371.
40. Daenen S, Vellenga E, van Dobbenbugh O A, et al. Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood, 1986, 67: 559-561.
41. Fontana J A, Roger I S, Durham J P. The role of 13-cis retinoic acid in the remission induction of a patient with acute promyelocytic leukemia. Cancer, 1986, 57: 209-217.
42. Chomienne C, Ballerini P, Balitrand N, et al. Retinoic acid therapy for promyelocytic leukemia. Lancet, 1989, 334: 746-747.
43. Castaigne S, Chomienne C, Daniel M T, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 1990, 76: 1704-1709.
44. Chen Z X, Xue Y Q, Zhang R, et al. A clinical and experimental study on all-trans retinoic acid treated acute promyelocytic leukemia patients. Blood, 1991, 78: 1413-1419.
45. Warrell Jr R P, Frankel S T, Miller Jr W H, et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med, 1991, 324: 1385-1393.
46. Tallman M S, Andersen J W, Schiffer C A, et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med, 1997, 337: 1021-1028.
47. Duan J X, Xin X M, Wang F Q, et al. Anti-cancer effect of Ailin No. 1 on leukemic cells of acute promyelocytic leukemia patients (in Chinese). Pract J Oncol, 1992, (2): 29-30.
48. Huang S L, Guo A X, Xiang Y, et al. Clinical study on the treatment of APL mainly with composite Indigo Naturalis tablets (in Chinese). Chin J Hematol, 1995, 16: 26.
49. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR α/PML proteins. Blood, 1996, 88: 1052-1061.
50. Xu J S, Duan J M, Xu Y, et al. A case of APL survival of 20 years with treatment by Ailin I (in Chinese). Chin J Hematol, 1997, 18: 476.
51. 3 exerts dose-dependent dual effects on APL cells. Blood, 1997, 89: 3345-3353.
52. 3) in the treatment of acute promyelocytic leukemia (APL), II: clinical efficacy and pharmacokinetics in relapsed patients. Blood, 1997, 89: 3354-3360.
53. Soignet S L, Maslak P, Wang Z G, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med, 1998, 339: 1341-1348.
54. Rosenthal E. Chairman Mao's cure for cancer. New York Times, May 6th, 2001.
55. Chen G Q, Chen S J, Wang Z Y, et al. (1998). Mechanisms and prospects of arsenic treatment of acute promyelocytic leukemia (in Chinese). Chin J Integrat Trad Chin West Med, 1998, 18: 581-582.
56. Mervis J. Cancer research: ancient remedy performs new tricks. Science, 1996, 273: 578.
57. Zhang T D, Chen G Q, Wang Z G, et al. Arsenic trioxide, a therapeutic agent for APL. Oncogene, 2001, 20: 7146-7153.
58. Zhu J, Chen Z, Lallemand-Breitenbach V, et al. How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer, 2001, 2: 705-714.
59. Wang Z Y, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood, 2008, 111: 2505-2515.
60. Niu C, Yan H, Yu T, et al. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood, 1999, 94: 3315-3324.
61. Chen S J, Zhou G B, Zhang X W, et al. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood, 2011, 117: 6425-6437.
62. Zhang P. The history of discovering arsenic trioxide (in Chinese). http://blog. sciencenet. cn/blog-870683-663068. html, 2013.
63. Au W Y, Kumana C R, Lee H K K, et al. Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study. Blood, 2011, 118: 6535-6543.
64. Li Y S, Zhang T D, Wang X R, et al. Investigation of the dynamics of Ailin No. 1 on human liver cancer cells (in Chinese). Res Cancer Prevent Treat, 1988, 15: 1-3.
65. Liu L X, Zhu A L, Chen W, et al. Effect of arsenic trioxide on hepatocellular carcinoma and its mechanistic studies. Chin J Surg, 2005, 43: 33-36.
66. Guo H X, Chen W, Liu L X, et al. Recent status of the effect of arsenic trioxide on colon cancer. Chin J Integr Trad West Med Dig, 2006, 14: 207-209.